Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Retrograde release of endocannabinoids inhibits presynaptic GABA release to second-order baroreceptive neurons in NTS.

Chen CY, Bonham AC, Dean C, Hopp FA, Hillard CJ, Seagard JL.

Auton Neurosci. 2010 Dec 8;158(1-2):44-50. doi: 10.1016/j.autneu.2010.06.001. Epub 2010 Jul 1.

2.

Endocannabinoid liberation from neurons in transsynaptic signaling.

Lovinger DM.

J Mol Neurosci. 2007 Sep;33(1):87-93. Review.

PMID:
17901551
3.

Retrograde endocannabinoid signaling in the cerebellar cortex.

Safo PK, Cravatt BF, Regehr WG.

Cerebellum. 2006;5(2):134-45. Review.

PMID:
16818388
4.

Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.

Sidhpura N, Parsons LH.

Neuropharmacology. 2011 Dec;61(7):1070-87. doi: 10.1016/j.neuropharm.2011.05.034. Epub 2011 Jun 12. Review.

5.

Plasticity of GABAergic mechanisms within the nucleus of the solitary tract in hypertension.

Zhang W, Mifflin S.

Hypertension. 2010 Feb;55(2):201-6. doi: 10.1161/HYPERTENSIONAHA.109.146407. Epub 2010 Jan 4. Review. No abstract available.

6.

Synaptic inhibition and γ-aminobutyric acid in the mammalian central nervous system.

Obata K.

Proc Jpn Acad Ser B Phys Biol Sci. 2013;89(4):139-56. Review.

7.

Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate.

Rea K, Roche M, Finn DP.

Br J Pharmacol. 2007 Nov;152(5):633-48. Epub 2007 Sep 10. Review.

8.

Endocannabinoids in the dentate gyrus.

Frazier CJ.

Prog Brain Res. 2007;163:319-37. Review.

Supplemental Content

Support Center